
Sign up to save your podcasts
Or


Editor Helen Frankish discusses highlights from the June issue: a randomised trial showing the efficacy of a ketogenic diet to protect against childhood epilepsy; and a trial with phase II results for the Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease.
By The Lancet NeurologyEditor Helen Frankish discusses highlights from the June issue: a randomised trial showing the efficacy of a ketogenic diet to protect against childhood epilepsy; and a trial with phase II results for the Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease.

43,589 Listeners

292 Listeners

518 Listeners

50 Listeners

112,200 Listeners

93 Listeners

513 Listeners

189 Listeners

61 Listeners

82 Listeners

0 Listeners